---
title: "U.S. Stock Market News | Weight-loss drug Zepbound expected to be approved in Japan next year, Eli Lilly up more than 1%"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/216588859.md"
description: "On Friday, Eli Lilly's stock price fluctuated upwards, rising by 1.18% to $921.435 at the time of publication. On the news front, Eli Lilly's CEO stated on Friday that the weight loss drug Zepbound is expected to be approved in Japan next year"
datetime: "2024-10-11T15:01:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/216588859.md)
  - [en](https://longbridge.com/en/news/216588859.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/216588859.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/216588859.md) | [繁體中文](https://longbridge.com/zh-HK/news/216588859.md)


# U.S. Stock Market News | Weight-loss drug Zepbound expected to be approved in Japan next year, Eli Lilly up more than 1%

According to the Smart Finance app, on Friday, Eli Lilly (LLY.US) stock price fluctuated upwards, rising by 1.18% to $921.435 at the time of publication. On the news front, Eli Lilly's CEO stated on Friday that the weight-loss drug Zepbound is expected to be approved in Japan next year

### 相关股票

- [Eli Lilly (LLY.US)](https://longbridge.com/zh-CN/quote/LLY.US.md)

## 相关资讯与研究

- [British drug-cost watchdog recommends use of Novo's Wegovy to lower heart risks](https://longbridge.com/zh-CN/news/281263193.md)
- [Eli Lilly just delivered fantastic news to investors](https://longbridge.com/zh-CN/news/269703566.md)
- [5 Simple ETFs to Buy With $1,000 and Hold for a Lifetime](https://longbridge.com/zh-CN/news/281345615.md)
- [Warren Buffett Admits He Sold Apple Too Early, Eyes Future Buying But Not Yet](https://longbridge.com/zh-CN/news/281336451.md)
- [BUZZ-Street View: Nike's turnaround remains work in progress](https://longbridge.com/zh-CN/news/281331333.md)